Cargando…
Should lifelong anticoagulation for unprovoked venous thromboembolism be revisited?
Venous thromboembolism [VTE] is a common medical condition that has significant morbidity and mortality. Although stringent guidelines recommend lifelong anticoagulation for patients with unprovoked VTE, the optimal management strategy for their long term treatment remains controversial. Whereas in...
Autores principales: | Moodley, Otto, Goubran, Hadi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618533/ https://www.ncbi.nlm.nih.gov/pubmed/26500456 http://dx.doi.org/10.1186/s12959-015-0063-z |
Ejemplares similares
-
Extended anticoagulation for unprovoked venous thromboembolism
por: Castellucci, Lana A., et al.
Publicado: (2018) -
Clinical outcomes of prolonged anticoagulation with rivaroxaban after unprovoked venous thromboembolism
por: Berger, Jeffrey S., et al.
Publicado: (2017) -
Screening for cancer in unprovoked venous thromboembolism
por: Shivji, Salma, et al.
Publicado: (2019) -
Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism
por: Wells, Philip S., et al.
Publicado: (2022) -
Extended anticoagulation after venous thromboembolism: should it be
done?
por: Fernandes, Caio J., et al.
Publicado: (2019)